161 related articles for article (PubMed ID: 1868116)
1. Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.
Boring DL; Ji XD; Zimmet J; Taylor KE; Stiles GL; Jacobson KA
Bioconjug Chem; 1991; 2(2):77-88. PubMed ID: 1868116
[TBL] [Abstract][Full Text] [Related]
2. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
Müller CE; Hide I; Daly JW; Rothenhäusler K; Eger K
J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
[TBL] [Abstract][Full Text] [Related]
3. Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors.
Jacobson KA; Barone S; Kammula U; Stiles GL
J Med Chem; 1989 May; 32(5):1043-51. PubMed ID: 2709373
[TBL] [Abstract][Full Text] [Related]
4. Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors.
Jacobson KA; Kiriasis L; Barone S; Bradbury BJ; Kammula U; Campagne JM; Secunda S; Daly JW; Neumeyer JL; Pfleiderer W
J Med Chem; 1989 Aug; 32(8):1873-9. PubMed ID: 2754711
[TBL] [Abstract][Full Text] [Related]
5. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
Shimada J; Suzuki F; Nonaka H; Ishii A
J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labeling.
Ji XD; Stiles GL; van Galen PJ; Jacobson KA
J Recept Res; 1992; 12(2):149-69. PubMed ID: 1583620
[TBL] [Abstract][Full Text] [Related]
7. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
Jacobson KA; Gallo-Rodriguez C; Melman N; Fischer B; Maillard M; van Bergen A; van Galen PJ; Karton Y
J Med Chem; 1993 May; 36(10):1333-42. PubMed ID: 8496902
[TBL] [Abstract][Full Text] [Related]
9. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
Sarges R; Howard HR; Browne RG; Lebel LA; Seymour PA; Koe BK
J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150
[TBL] [Abstract][Full Text] [Related]
10. 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.
Shamim MT; Ukena D; Padgett WL; Hong O; Daly JW
J Med Chem; 1988 Mar; 31(3):613-7. PubMed ID: 3346878
[TBL] [Abstract][Full Text] [Related]
11. Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
Jacobson KA; Stiles GL; Ji XD
Mol Pharmacol; 1992 Jul; 42(1):123-33. PubMed ID: 1635550
[TBL] [Abstract][Full Text] [Related]
12. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
13. 125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.
Linden J; Patel A; Earl CQ; Craig RH; Daluge SM
J Med Chem; 1988 Apr; 31(4):745-51. PubMed ID: 3351850
[TBL] [Abstract][Full Text] [Related]
14. Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
Ukena D; Jacobson KA; Padgett WL; Ayala C; Shamim MT; Kirk KL; Olsson RO; Daly JW
FEBS Lett; 1986 Dec; 209(1):122-8. PubMed ID: 3803571
[TBL] [Abstract][Full Text] [Related]
15. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
16. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
Cunha RA; Constantino MD; Ribeiro JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):295-302. PubMed ID: 10344528
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
Bruns RF; Lu GH; Pugsley TA
Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
[TBL] [Abstract][Full Text] [Related]
18. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
Nonaka H; Mori A; Ichimura M; Shindou T; Yanagawa K; Shimada J; Kase H
Mol Pharmacol; 1994 Nov; 46(5):817-22. PubMed ID: 7969067
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.
Mazzoni MR; Buffoni RS; Giusti L; Lucacchini A
J Recept Signal Transduct Res; 1995; 15(7-8):905-29. PubMed ID: 8673723
[TBL] [Abstract][Full Text] [Related]
20. Functionalized congeners of adenosine: preparation of analogues with high affinity for A1-adenosine receptors.
Jacobson KA; Kirk KL; Padgett WL; Daly JW
J Med Chem; 1985 Sep; 28(9):1341-6. PubMed ID: 2993623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
